Research ArticleClinical Investigation
Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
Philipp Backhaus, Matthias C. Burg, Inga Asmus, Michaela Pixberg, Florian Büther, Hans-Jörg Breyholz, Randy Yeh, Stefanie B. Weigel, Patricia Stichling, Walter Heindel, Stefanie Bobe, Peter Barth, Joke Tio and Michael Schäfers
Journal of Nuclear Medicine May 2023, 64 (5) 717-723; DOI: https://doi.org/10.2967/jnumed.122.264871
Philipp Backhaus
Matthias C. Burg
4Clinic for Radiology, University Hospital Münster, Münster, Germany;
Inga Asmus
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany;
Michaela Pixberg
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany;
Florian Büther
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany;
2European Institute for Molecular Imaging, University of Münster, Münster, Germany;
Hans-Jörg Breyholz
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany;
Randy Yeh
3Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York;
Stefanie B. Weigel
4Clinic for Radiology, University Hospital Münster, Münster, Germany;
Patricia Stichling
4Clinic for Radiology, University Hospital Münster, Münster, Germany;
Walter Heindel
4Clinic for Radiology, University Hospital Münster, Münster, Germany;
Stefanie Bobe
2European Institute for Molecular Imaging, University of Münster, Münster, Germany;
5Gerhard-Domagk Institute for Pathology, University of Münster, Münster, Germany; and
Peter Barth
5Gerhard-Domagk Institute for Pathology, University of Münster, Münster, Germany; and
Joke Tio
6Department of Gynecology and Obstetrics, University Hospital Münster, Münster, Germany
Michael Schäfers
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany;
2European Institute for Molecular Imaging, University of Münster, Münster, Germany;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 64, Issue 5
May 1, 2023
Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
Philipp Backhaus, Matthias C. Burg, Inga Asmus, Michaela Pixberg, Florian Büther, Hans-Jörg Breyholz, Randy Yeh, Stefanie B. Weigel, Patricia Stichling, Walter Heindel, Stefanie Bobe, Peter Barth, Joke Tio, Michael Schäfers
Journal of Nuclear Medicine May 2023, 64 (5) 717-723; DOI: 10.2967/jnumed.122.264871
Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
Philipp Backhaus, Matthias C. Burg, Inga Asmus, Michaela Pixberg, Florian Büther, Hans-Jörg Breyholz, Randy Yeh, Stefanie B. Weigel, Patricia Stichling, Walter Heindel, Stefanie Bobe, Peter Barth, Joke Tio, Michael Schäfers
Journal of Nuclear Medicine May 2023, 64 (5) 717-723; DOI: 10.2967/jnumed.122.264871
Jump to section
Related Articles
Cited By...
- Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer with [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI: Lesion-to-Lesion Comparison with Pathology
- [18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
- 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study